A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers
Primary Purpose
Head and Neck Cancer, Dysphagia
Status
Unknown status
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
Codetron ALTENS
Sponsored by
About this trial
This is an interventional supportive care trial for Head and Neck Cancer focused on measuring Radiation Treatment, Head and Neck Cancer, Dysphagia
Eligibility Criteria
Inclusion Criteria:This study will recruit patients with head and neck cancers treated with radiation+/- chemotherapy and who meet the following criteria (EAT-10 assessment will be used for screening):
Inclusion Criteria
- present with dysphagia symptoms
- with no evidence of residue cancer
- are within 3 months (but past 1 month) after treatment completion
- show positive dysphagia (EAT-10 score of > 3) and/ or aspiration on barium swallow study
- are over 18 years old
- are able to read and write fluent English
- can give informed consent
Exclusion Criteria:
- have unstable heart disease
- have infectious disease transmissible by blood or body fluid, including hepatitis and HIV
- have skin disease at site of study acupuncture points that prevents the application of electrodes
Sites / Locations
- Juravinski Cancer Centre
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
ALTENS
Arm Description
Patients in this arm will be treated with Acupuncture-like Transcutaneous Electrical Nerve Stimulation using Codetron (Codetron ALTENS)
Outcomes
Primary Outcome Measures
Change in Subjective Dysphagia Assessment Score: EAT-10 from baseline
EAT-10 is a self-administered questionnaire for subjective assessment of dysphagia. It consists of 10 items and each item is scored using a 5-point Likert scale. The higher the point, the more severe the problem being scored. Normative data suggested that a total score of 3 or higher is abnormal.
Secondary Outcome Measures
Change in M. D. Anderson dysphagia inventory from baseline
M. D. Anderson dysphagia inventory (MDADI) is a self-administered questionnaire designed specifically to assess the quality of life for head and neck cancer patients who suffer from dysphagia. It incorporated three domains: emotional, functional and physical, and one global question. There are a total of 20 items.Each item is scored on a scale of 1 to 5 with 1 being strongly agree and 5 strongly disagree except for two items, one on the emotional subscale and the other on the functional subscale. The global question is scored and interpreted separately. The scores of all the items in each domain are summed and a mean score is calculated. The final score for each subscale is calculated by multiplying the calculated mean score by 20 with a final range from 0 to 100. The final score of the global question is also calculated in the same way. The higher the final score represents better functioning and quality of life.
Full Information
NCT ID
NCT01697891
First Posted
September 26, 2012
Last Updated
October 1, 2012
Sponsor
McMaster University
Collaborators
Hamilton Health Sciences Corporation
1. Study Identification
Unique Protocol Identification Number
NCT01697891
Brief Title
A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers
Official Title
Effectiveness of Acupuncture-like Transcutaneous Nerve Stimulation (ALTENS) in Improving Dysphagia and Associated Symptoms of Chemotherapy and/or Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancers: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2012
Overall Recruitment Status
Unknown status
Study Start Date
October 2012 (undefined)
Primary Completion Date
September 2013 (Anticipated)
Study Completion Date
December 2013 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McMaster University
Collaborators
Hamilton Health Sciences Corporation
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Study hypothesis: ALTENS techniques, administered within the first 3 months after radiation completion, can improve radiation-induced dysphagia and associated symptoms in head and neck cancer patients. This beneficial effect is mediated by the reduction of chronic inflammatory response of swallowing musculature to radiation, consequently a reduction in muscle fibrosis.
Primary study objective: To evaluate the effectiveness of ALTENS in relieving radiation-induced dysphagia. Eating Assessment Tool (EAT-10) scores will be used for this primary study endpoint.
Detailed Description
Difficulty in swallowing is a concerning symptom after radiation treatment for some types of head and neck cancers. Swallowing becomes difficult when radiation damage induces inflammation (with swelling and pain) in the inner covering tissues of the throat and muscles that involve in the swallowing process. Currently, supportive measures are used to manage this symptom while waiting for the tissue damages to heal. In some patients, the inflamed muscles develop scar tissues causing long-term swallowing difficulty and narrowing of the swallowing passage. Needle acupuncture may help to reduce tissue inflammation and may lessen the severity of swallowing difficulty. However, needle puncture is often not desired by patients. Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) is like acupuncture treatment, but the acupuncture points are stimulated with mild electrical stimulation without needles, simplifying treatment delivery. This study is to examine if a pre-selected set of acupuncture points treated using ALTENS can reduce swallowing difficulty. There will be a total of 12 treatments given over 6 to 8 weeks. Changes in severity of swallowing difficult after treatment will be assessed using 2 subjective assessment tools.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Cancer, Dysphagia
Keywords
Radiation Treatment, Head and Neck Cancer, Dysphagia
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ALTENS
Arm Type
Experimental
Arm Description
Patients in this arm will be treated with Acupuncture-like Transcutaneous Electrical Nerve Stimulation using Codetron (Codetron ALTENS)
Intervention Type
Device
Intervention Name(s)
Codetron ALTENS
Intervention Description
ALTENS stimulation of a set of selected acupuncture points for 20 minutes in each treatment. Two treatments per week for a total of 12 treatments to be delivered within 8 weeks.
Primary Outcome Measure Information:
Title
Change in Subjective Dysphagia Assessment Score: EAT-10 from baseline
Description
EAT-10 is a self-administered questionnaire for subjective assessment of dysphagia. It consists of 10 items and each item is scored using a 5-point Likert scale. The higher the point, the more severe the problem being scored. Normative data suggested that a total score of 3 or higher is abnormal.
Time Frame
3 months after treatment completion
Secondary Outcome Measure Information:
Title
Change in M. D. Anderson dysphagia inventory from baseline
Description
M. D. Anderson dysphagia inventory (MDADI) is a self-administered questionnaire designed specifically to assess the quality of life for head and neck cancer patients who suffer from dysphagia. It incorporated three domains: emotional, functional and physical, and one global question. There are a total of 20 items.Each item is scored on a scale of 1 to 5 with 1 being strongly agree and 5 strongly disagree except for two items, one on the emotional subscale and the other on the functional subscale. The global question is scored and interpreted separately. The scores of all the items in each domain are summed and a mean score is calculated. The final score for each subscale is calculated by multiplying the calculated mean score by 20 with a final range from 0 to 100. The final score of the global question is also calculated in the same way. The higher the final score represents better functioning and quality of life.
Time Frame
3 months after treatment completion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:This study will recruit patients with head and neck cancers treated with radiation+/- chemotherapy and who meet the following criteria (EAT-10 assessment will be used for screening):
Inclusion Criteria
present with dysphagia symptoms
with no evidence of residue cancer
are within 3 months (but past 1 month) after treatment completion
show positive dysphagia (EAT-10 score of > 3) and/ or aspiration on barium swallow study
are over 18 years old
are able to read and write fluent English
can give informed consent
Exclusion Criteria:
have unstable heart disease
have infectious disease transmissible by blood or body fluid, including hepatitis and HIV
have skin disease at site of study acupuncture points that prevents the application of electrodes
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raimond Wong, MD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Juravinski Cancer Centre
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8V5C2
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers
We'll reach out to this number within 24 hrs